$Kweichow Moutai Co.,Ltd.(600519)$$Myovant Sciences Ltd.(MYOV)$MYOV now Trading below its IPO price when there was nothing… 2 blockbuster drugs approved and commercialization by Pfizer at tiered payment of 4.2billion for half the sales. Sales has started and growing steadily with good reviews from practicitors… One more drug pending approval and Sumi looking at acquiring the last “vant” company to make upfor the patent cliff made MYOV an irresitiable target to buy.. another contender will be Pfizer who is flooded with cash and out on a buying spree.. either one move and we will have a winner here… trading well below valuation at this price…Greatvalue at 3 times better price to sales ratio versus last quarter and 20x better enterprise value vs EBITA ratio